Skip to main content
SpringerLink
Log in

Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism

  • Animal Studies
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effects of drugs acting on muscarinic cholinergic receptors on the catalepsy, antinociception and changes in rectal temperature and in brain dopamine metabolism induced by morphine were studied in Wistar rats. Scopolamine (0.3–30 mg/kg) was about three times as potent as atropine (1–30 mg/kg) in potentiating the cataleptic effect of morphine. Methylscopolamine and methylatropine did not alter the cataleptic effect of morphine. Pilocarpine (100 mg/kg) and arecoline (10 mg/kg) slightly but significantly and RS86 (20–40 mg/kg) clearly antagonized the morphine-catalepsy. RS86 antagonized the atropineinduced potentiation of morphine catalepsy. The antinocieptive effect of pilocarpine was additive and that of RS86 less than additive with morphine. The antimuscarinic compounds did not alter the antinociceptive effect of morphine. Antimuscarinic compounds enhanced the hypothermic effect of morphine, but none of the compounds studied altered the hyperthermic effect of morphine. The antimuscarinic drugs reduced the concentration of striatal homovanillic acid (HVA) in about same proportion in control and morphine-treated rats. Both the muscarinic compounds and morphine increased the concentration of striatal HVA, but when combined their effects were not significantly different from those of inorphine alone. Scopolamine antagonized and pilocarpine accelerated the morphine-induced increase in the rate of depletion of cerebral dopamine content. The present results show that the effects of muscarinic and antimuscarinic cholinergic drugs on the cataleptic effect of morphine were opposite to their effects on the catalepsy induced by neuroleptic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahtee, L.: Effect of cholinergic drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone. Europ. J. Pharmacol. 39, 203–213 (1976)

    Google Scholar 

  • Ahtee, L., Kaakkola, S.: Effects of drugs acting on cholinergic receptors on the catalepsy and stereotypies induced by morphine and methadone in rats. Satellite Symposium to 6th Internat. Congress of Pharmacology, Abstracts, pp. 20–21, Espoo, July 18–20, 1975

  • Ahtee, L., Kääriäinen, I.: The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Europ. J. Pharmacol. 22, 206–208 (1973)

    Google Scholar 

  • Ahtee, L., Kääriäinen, I.: The role of dopamine in pilocarpineinduced catalepsy. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 25–38 (1974)

    Google Scholar 

  • Ahtee, L., Kääriäinen, I., Paasonen, M. K.: Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus. Ann. Med. exp. Fenn. 50, 180–185 (1972)

    Google Scholar 

  • Andén, N.-E.: Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system. J. Pharm. Pharmacol. 26, 738–740 (1974)

    Google Scholar 

  • Andén, N.-E., Bédard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)

    Google Scholar 

  • Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experientia (Basel) 27, 1302–1303 (1971)

    Google Scholar 

  • Cashin, C. H., Sutton, S.: The effect of anti-Parkinson drugs on catalepsy induced by α-methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine. Brit. J. Pharmacol. 47, 658P-659P (1973)

    Google Scholar 

  • Corrodi, H., Fuxe, K., Hammer, W., Sjöqvist, F., Ungerstedt, U.: Oxotremorine and central monoamine neurons. Life Sci. 6, 2557–2566 (1967)

    Google Scholar 

  • Corrodi, H., Fuxe, K., Lidbrink, P.: Interaction between choliergic and catecholaminergic neurons in rat brain. Brain Res. 43, 397–416 (1972)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Modification of amphetamine effects by intracerebrally administered anticholinergic agents. Life Sci. 11, 239–253 (1972)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forsch 23, 674–683 (1973)

    Google Scholar 

  • Dahlström, B., Paalzow, G., Paalzow, L.: A pharmacokinetic approach to morphine analgesia and its relation to regional turnover of rat brain catecholamines. Life Sci 17, 11–16 (1975)

    Google Scholar 

  • Evans, W. O.: A new technique for the investigation of some analgesic drugs on a reflexive behavior in the rat. Psychopharmacologia (Berl.) 2, 318–325 (1961)

    Google Scholar 

  • Friedman, A., Everett, G. M.: Pharmacological aspects of parkinsonism. In: Advances in pharmacology, Vol. 3, S. Garattini and P. A. Shore, eds., pp. 83–127. New York-London: Academic Press 1964

    Google Scholar 

  • Fukui, K., Takagi, H.: Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action. Brit. J. Pharmacol. 44, 45–51 (1972)

    Google Scholar 

  • Gunne, L. M., Jonsson, J., Fuxe, K.: Effects of morphine intoxication on brain catecholamine neurons. Europ. J. Pharmacol 5, 338–342 (1969)

    Google Scholar 

  • Herz, A.: Über die Beeinflussung zentral dämpfender und erregender Morphinwirkungen durch Anticholinergica, Nicotinolytica und Antihistaminica an der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 241, 236–253 (1961)

    Google Scholar 

  • Herz, A.: Wirkungen des Arecolins auf das Zentralnervensystem. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 242, 414–429 (1962)

    Google Scholar 

  • Herz, A., Metyš, J.: Inhibition of nociceptive responses by substances acting on central cholinoceptive systems. In: Pain, A. Soulairac, J. Cahn, and J. Charpentier, eds., pp. 321–334. New York-London: Academic Press 1968

    Google Scholar 

  • Houser, V. P., Van Hart, D. A.: The effects of scopolamine and pilocarpine upon the aversive threshold of the rat. Pharmacol. Biochem. Behav. 1, 427–431 (1973)

    Google Scholar 

  • Howes, J. F., Harris, L. S., Dewey, W. L., Voyda, C. A.: Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. J. Pharmacol. exp. Ther. 169, 23–28 (1969)

    Google Scholar 

  • Ireson, J. D.: A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs. Brit. J. Pharmacol. 40, 92–101 (1970)

    Google Scholar 

  • Jacob, J., Barthelemy, C.: Antinociceptive effects of morphine and central cholinergic systems. In: Pain, R. Janzen, W. D. Keidel, A. Herz, and C. Steichele, eds., pp. 236–239, Stuttgart: Thieme 1972

    Google Scholar 

  • Kaakkola, S., Ahtee, L.: Effect of anticholinergics and cholinomimetics on morphine-catalepsy in rats. 6th Internat. Congress of Pharmacology, Abstracts, p. 270, Helsinki, Finland, July 20–25, 1975

  • Koelle, G. B.: Parasympathomimetic agents. In: The pharmacological basis of therapeutics, 5th ed., L. S. Goodman and A. Gilman, eds., pp. 467–476, New York: MacMillan 1975

    Google Scholar 

  • Kuschinsky, K.: Evidence that morphine increases dopamine utilization in corpora striata of rats. Experientia (Basel) 29, 1365–1366 (1973)

    Google Scholar 

  • Kuschinsky, K.: Are cholinergic mechanisms involved in morphine effects on motility? Naunyn-Schmiedeberg's Arch. Pharmacol. 281, 167–173 (1974)

    Google Scholar 

  • Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Europ. J. Pharmacol. 19, 119–122 (1972)

    Google Scholar 

  • Kääriäinen, I., Vikberg, P.: Effects of aminooxyacetic acid and baclofen on catalepsy, striatal homovanillic acid increase and antinociception caused by methadone in rats. Acta pharmacol. (Kbh.) 39, 536–544 (1976)

    Google Scholar 

  • Laverty, R., Sharman, D. F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit. J. Pharmacol. 24, 759–772 (1965)

    Google Scholar 

  • Lotti, V. J.: Body temperature responses to morphine. In: The pharmacology of thermoregulation. Symp., E. Schönbaum and P. Lomax, eds., pp. 382–394. Basel: Karger 1973

    Google Scholar 

  • Morpurgo, C.: Effects of antiparkinson drugs on phenthiazineinduced catonic reaction. Arch. int. Pharmacodyn. 137, 84–90 (1962)

    Google Scholar 

  • Nose, T., Takemoto, H.: Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat. Europ. J. Pharmacol. 25, 51–55 (1974)

    Google Scholar 

  • O'Keeffe, R., Sharman, D. F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970)

    Google Scholar 

  • Parkes, M. W.: An examination of central actions characteristic of scopolamine: comparison of central and peripheral activity in scopolamine, atropine and some synthetic basic esters. Psychopharmacologia (Berl.) 7, 1–19 (1965)

    Google Scholar 

  • Perez-Cuet, J., DiChiara, G., Gessa, G. L.: Accelerated synthesis of dopamine in the rat brain after methadone. Experientia (Basel) 28, 926 (1972)

    Google Scholar 

  • Pleuvry, B. J., Tobias, M. A.: Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Brit. J. Pharmacol. 43, 706–714 (1971)

    Google Scholar 

  • Portig, P. J., Sharman, D. F., Vogt, M.: Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus. J. Physiol. (Lond.) 194, 565–572 (1968)

    Google Scholar 

  • Puri, S. K., Reddy, C., Lal, H.: Blockade of central dopaminergic receptors by morphine: effect of haloperidol, apomorphine or benztropine. Res. Commun. Chem. Path. Pharmacol. 5, 389–401 (1973)

    Google Scholar 

  • Sasame, H. A., Perez-Cruet, J., DiChiara, G., Tagliamonte, A., Tagliamonte, P., Gessa, G. L.: Evidence that methadone blocks dopamine receptors in the brain. J. Neurochem. 19, 1953–1957 (1972)

    Google Scholar 

  • Sharman, D. F.: A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse. Brit. J. Pharmacol. 30, 620–626 (1967)

    Google Scholar 

  • Shellenberger, M. K., Gordon, J. H.: A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine and 5-hydroxytryptamine from discrete brain areas. Analyt. Biochem. 39, 356–372 (1971)

    Google Scholar 

  • Simon, P., Malatray, J., Boissier, J. R.: Antagonism by amantadine of prochlorpemazine-induced catalepsy. J. Pharm. Pharmacol. 22, 546–547 (1970)

    Google Scholar 

  • Smelik, P. G., Ernst, A. M.: Role of nigro-neostriatal dopaminergic fibres in compulsive gnawing behavior in rats. Life Sci. 5, 1485–1488 (1966)

    Google Scholar 

  • Stadler, H., Lloyd, K. G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)

    Google Scholar 

  • Sugrue, M. F.: The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain. Brit. J. Pharmacol. 52, 159–165 (1974)

    Google Scholar 

  • Takemori, A. E., Tulunay, F. C., Yano, I.: Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers. Life Sci. 17, 21–28 (1975)

    Google Scholar 

  • Tulunay, F. C., Yano, I., Takemori, A. E.: The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Europ. J. Pharmacol 35, 285–292 (1976)

    Google Scholar 

  • Van Eick, A. J., Bock, J.: Comparison of analgesic, cholinomimetic, anticholinergic and sympathomimetic drugs by means of the hot-plate test. Arch. int. Pharmacodyn. 189, 384–387 (1971)

    Google Scholar 

  • Zetler, G.: Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. Int. J. Neuropharmacol 7, 325–335 (1968)

    Google Scholar 

  • Yaksh, T. L., Yamamura, H. I.: Blockade by morphine of acetylcholine release from the caudate nucleus in the mid-pontine pretrigeminal cat. Brain Res 83, 520–524 (1975)

    Google Scholar 

Download references

Author information

Author notes

  1. Liisa Ahtee

    Present address: School of Pharmacy, Department of Pharmacology, University of Helsinki, Kirkkokatu 20, SF-00170, Helsinki 17, Finland

Authors and Affiliations

  1. Department of Pharmacology, University of Helsinki, Siltavuorenpenger 10, SF-00170, Helsinki 17, Finland

    Seppo Kaakkola & Liisa Ahtee

Authors
  1. Seppo Kaakkola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liisa Ahtee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaakkola, S., Ahtee, L. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism. Psychopharmacology 52, 7–15 (1977). https://doi.org/10.1007/BF00426593

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426593

Key words

Search

Navigation